Scinai regains Nasdaq compliance with $1 minimum bid price rule
Nasdaq confirmed Scinai Immunotherapeutics Ltd. regained compliance with the $1 minimum bid price rule, with its American Depositary Shares closing at or above $1 for 19 consecutive sessions from Aug. 21 to Sept. 17. Nasdaq closed the minimum bid price compliance matter after issuing a deficiency notice on March 12, 20